Eli Lilly and Company (United States)

Eli Lilly and Company is a global pharmaceutical leader headquartered in Indianapolis, Indiana. The company develops breakthrough treatments in diabetes, oncology, immunology, and neuroscience. Key products include Mounjaro (tirzepatide) and Zepbound for type 2 diabetes and weight loss, Trulicity (dulaglutide) for diabetes, Verzenio (abemaciclib) for breast cancer, Taltz (ixekizumab) for psoriasis, and Emgality (galcanezumab) for migraine prevention. Lilly’s innovative research continues advancing treatments for obesity, Alzheimer’s disease, and other serious conditions.